Data type
Healthcare data providers
Healthcare data providers sell provider directories, claims and de-identified patient data; what each is, who buys it, and what HIPAA permits.
Published
What is a healthcare data provider?
A healthcare data provider licenses information about the health system, such as provider and facility directories, claims, prescriptions or de-identified clinical records, to life sciences firms, insurers, researchers and health technology companies.
Two very different markets under one name
Commercial intelligence
Searchers for this term often want one of two things. The first is commercial intelligence about the health system: which hospitals exist, which physicians work where, what they prescribe in aggregate, how health systems are organised.
Patient-level data
The second is patient-level data, nearly always de-identified, used for research, drug development, outcomes studies and AI. The first is mostly business data with modest privacy risk. The second is one of the most tightly regulated data markets in the country.
Which law governs which data
| Data category | Typical buyers | Main rule | How it can be licensed |
|---|---|---|---|
| Provider and facility directories | Medical device and pharma sales teams, staffing firms | Mostly public or business data; outreach laws apply | Standard commercial licence |
| Protected health information from covered entities | Researchers, analytics firms | HIPAA Privacy Rule | Only after de-identification, as a limited data set under a data use agreement, or with patient authorisation |
| De-identified claims and records | Life sciences, payers, AI developers | HIPAA de-identification standard | Safe Harbor removal of 18 identifiers, or an expert determination that re-identification risk is very small |
| Consumer health data outside HIPAA (apps, wearables, purchases) | Advertisers, researchers | Washington My Health My Data Act and similar state laws; FTC Act | Selling in Washington needs a signed authorisation that expires within a year |
| Location near health facilities | Advertisers | Washington geofencing ban; FTC location orders | Generally avoid |
De-identification in practice
HIPAA allows de-identified data to leave its protections entirely. There are two routes. Safe Harbor removes eighteen categories of identifiers, including names, most dates other than year, geographic units smaller than a state (with a narrow exception for three-digit ZIP codes covering over 20,000 people) and ages over 89, and requires that the holder has no actual knowledge the rest could identify someone.
Expert Determination lets a qualified statistician certify that the risk of re-identification is very small, which keeps more useful detail such as dates of service. Most commercial real-world data relies on the second route, and buyers usually ask to see the expert's report.
What it costs
- Definitive Healthcare median yearly (33 purchases)
- $50,000
- Reported range
- $20,777–$255,973
Commercial healthcare intelligence platforms are sold by yearly contract. Vendr reports a median of $50,000 yearly for Definitive Healthcare across 33 purchases, ranging from $20,777 to $255,973. Patient-level de-identified datasets are priced per project, cohort or data refresh and are not publicly benchmarked; we don't give a range for them.
What buyers check
- 1
Source and permissions
Which covered entities or apps supplied the data, and under what agreements.
- 2
De-identification method
Safe Harbor or Expert Determination, who certified it and when it expires.
- 3
Linkage rules
Whether tokens allow joining to other datasets, and whether that joining was within the expert's assessment.
- 4
Onward use
Bans on re-identification, on resale, and on use for eligibility or marketing decisions.
How DataBroker relates to this
DataBroker doesn't hold or sell health data. It is a paid programme of lessons and deal tools for people who broker datasets between organisations. Healthcare is a field where we advise new brokers to start with business data, such as facility and practice directories, and to treat patient-derived datasets as deals that need specialist counsel from the first call.
Sources
5 sources · checked Nov 7, 2026
The DataBroker team checked the facts on this page against 5 public sources, last on .
- Guidance regarding methods for de-identification of protected health information, US Department of Health and Human ServicesChecked
- New guidance on de-identification methods under the HIPAA Privacy Rule, Military Health SystemChecked
- Washington's My Health My Data Act: are you prepared?, VenableChecked
- Washington State expands privacy protections for health data, AkinChecked
- Definitive Healthcare pricing data, VendrChecked
Healthcare data providers FAQ
Can hospitals sell patient data?
Not identifiable patient data without authorisation. HIPAA generally bars selling protected health information, but properly de-identified data falls outside the rule and can be licensed.
Is health app data covered by HIPAA?
Usually not, unless the app works for a covered entity. It can still be covered by state laws such as Washington's My Health My Data Act and by the FTC's rules on unfair practices.
What is a limited data set?
A HIPAA category that keeps some identifiers, such as dates and town, and may be shared only for research, public health or operations under a data use agreement. It is not de-identified.
Who buys de-identified health data?
Pharmaceutical and device companies, insurers, academic researchers, consultancies and health AI developers, mainly for research, market analysis and model training.
Related
- Best business data providers
Best business data providers grouped by data type, with who buys each kind, how it is priced and which rules apply.
- B2B data providers
B2B data providers compared by pricing model, record source and compliance risk, with cited contract figures and a short buyer's checklist.
Join the DataBroker academy
The DataBroker academy and tools: find companies with data to sell, price it, license it and close the deal.






